Functional protective effects of long-term memantine treatment in the DBA/2J mouse

Documenta Ophthalmologica

Volumn 126, Issue 3, 2013, Pages 221-232

  Atorf, Jenny ^a   Scholz, Michael ^b   Garreis, Fabian ^b   Lehmann, Julia ^b   Bräuer, Lars ^b   Kremers, Jan ^a,c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Rhenovia Pharma   (France)

Author keywords

DBA 2J mouse; Electroretinography; Memantine; Neurodegeneration

Indexed keywords

GLUTAMIC ACID; MEMANTINE;

A WAVE; ANIMAL TISSUE; ARTICLE; B WAVE; CELL LOSS; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DEGENERATION; DRUG EFFECT; ELECTRORETINOGRAM; FEMALE; GLIA CELL; INTRAOCULAR PRESSURE; LONG TERM CARE; MORPHOLOGICAL TRAIT; MOUSE; NERVE FIBER; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PHOTORECEPTOR; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RETINA; VISUAL ADAPTATION;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, ANGLE-CLOSURE; INTRAOCULAR PRESSURE; MEMANTINE; MICE; MICE, INBRED DBA; MICROSCOPY, CONFOCAL; RETINA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878755751     PISSN: 00124486     EISSN: 15732622     Source Type: Journal    
DOI: 10.1007/s10633-013-9380-3     Document Type: Article

References (52)

1. Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, Wiggs JL, John SWM (2002) Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 30(1):81-85
2. John SWM, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull M, Roderick TH, Heckenlively JR (1998) Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39(6):951-962
3. Chang B, Smith RS, Hawes NL, Anderson MG, Zabaleta A, Savinova O, Roderick TH, Heckenlively JR, Davisson MT, John SW (1999) Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet 21(4):405-409. doi: 10.1038/7741
4. Libby RT, Anderson MG, Pang IH, Robinson ZH, Savinova OV, Cosma IM, Snow A, Wilson LA, Smith RS, Clark AF, John SWM (2005) Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci 22(5):637-648
5. Saleh M, Nagaraju M, Porciatti V (2007) Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 48(10):4564-4572
6. Scholz M, Buder T, Seeber S, Adamek E, Becker CM, Lütjen-Drecoll E (2008) Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest Ophthalmol Vis Sci 49(2):613-621
7. Moon JI, Kim IB, Gwon JS, Park MH, Kang TH, Lim EJ, Choi KR, Chun MH (2005) Changes in retinal populations in the DBA/2J mouse. Cell Tissue Res 320(1):51-59
8. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW (2006) Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7:66
9. Porciatti V, Saleh M, Nagaraju M (2007) The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci 48(2):745-751
10. Harazny J, Scholz M, Buder T, Lausen B, Kremers J (2009) Electrophysiological deficits in the retina of the DBA/2J mouse. Doc Ophthalmol 119(3):181-197
11. Barabas P, Huang W, Chen H, Koehler CL, Howell G, John SW, Tian N, Renteria RC, Krizaj D (2011) Missing optomotor head-turning reflex in the DBA/2J mouse. Invest Ophthalmol Vis Sci 52(9):6766-6773. doi: 10.1167/iovs.10-7147
12. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1(8):623-634
13. Meldrum B, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11(9):379-387
14. Lipton SA, Rosenberg RA (1994) Mechanisms of disease: excitatory amino acids as a final common pathway in neurologic disorders. N Engl J Med 330(9):613-622
15. Lucas DR, Newhouse JP (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58(2):193-201
16. Olney JW (1969) Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 28(3):455-474
17. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB (1996) Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 37(8):1618-1624
18. Hare WA, Wheeler L (2009) Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine. Invest Ophthalmol Vis Sci 50(6):2940-2948
19. Clapham DE (1995) Calcium signaling. Cell 80(2):259-268
20. Schanne FA, Kane AB, Young EE, Farber JL (1979) Calcium dependence of toxic cell death: a final common pathway. Science 206(4419):700-702
21. Trump BF, Berezesky IK (1995) Calcium-mediated cell injury and cell death. FASEB J 9(2):219-228
22. Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166(3):591-592
23. Kornhuber J, Bormann J, Retz W, Hubers M, Riederer P (1989) Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166(3):589-590
24. Seif el Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J (1990) Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 185(1):19-24
25. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12(11):4427-4436
26. Lipton SA (1993) Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci 16(12):527-532
27. Schneider E, Fischer PA, Clemens R, Balzereit F, Fünfgeld EW, Haase HJ (1984) Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study. Dtsch Med Wochenschr 109(25):987-990. doi: 10.1055/s-2008-1069311
28. Greenamyre JT, O'Brien CF (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch Neurol 48(9):977-981
29. Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F (2002) Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 33(7):1834-1839
30. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348(14):1333-1341. doi: 10.1056/NEJMoa013128
31. Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 33(4):403-407. doi: 10.1002/ana.410330414
32. Lagreze WA, Knorle R, Bach M, Feuerstein TJ (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 39(6):1063-1066
33. Schuettauf F, Quinto K, Naskar R, Zurakowski D (2002) Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res 42(20):2333-2337
34. Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS (2007) Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 48(3):1212-1218. doi: 10.1167/iovs.06-0757
35. Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, Ellisman MH, Weinreb RN (2009) Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 50(2):707-716. doi: 10.1167/iovs.08-2499
36. Filippopoulos T, Matsubara A, Danias J, Huang W, Dobberfuhl A, Ren L, Mittag T, Miller JW, Grosskreutz CL (2006) Predictability and limitations of non-invasive murine tonometry: comparison of two devices. Exp Eye Res 83(1):194-201
37. Goldblum D, Kontiola AI, Mittag T, Chen B, Danias J (2002) Non-invasive determination of intraocular pressure in the rat eye. Comparison of an electronic tonometer (TonoPen), and a rebound (impact probe) tonometer. Graefes Arch Clin Exp Ophthalmol 240:942-946
38. Danias J, Kontiola AI, Filippopoulos T, Mittag T (2003) Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci 44(3):1138-1141
39. Zhang K, Yao G, Gao Y, Hofeldt KJ, Lei B (2007) Frequency spectrum and amplitude analysis of dark- and light-adapted oscillatory potentials in albino mouse, rat and rabbit. Doc Ophthalmol 115(2):85-93
40. Birke MT, Neumann C, Birke K, Kremers J, Scholz M (2010) Changes of osteopontin in the aqueous humor of the DBA/2J glaucoma model correlated with optic nerve and RGC degenerations. Invest Ophthalmol Vis Sci 51(11):5759-5767. doi: 10.1167/iovs.10-5558
41. Inman DM, Sappington RM, Horner PJ, Calkins DJ (2006) Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci 47(3):986-996
42. Howell GR, Libby RT, Marchant JK, Wilson LA, Cosma IM, Smith RS, Anderson MG, John SW (2007) Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet 8:45
43. Samuel MA, Zhang Y, Meister M, Sanes JR (2011) Age-related alterations in neurons of the mouse retina. J Neurosci 31(44):16033-16044. doi: 10.1523/jneurosci.3580-11.2011
44. Stockton RA, Slaughter MM (1989) B-wave of the electroretinogram: a reflection of ON bipolar activity. J Gen Physiol 93(1):101-122
45. Hare WA, WoldeMussie E, Lai RK, Ton H, Ruiz G, Chun T, Wheeler L (2004) Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey I: functional measures. Invest Ophthalmol Vis Sci 45(8):2625-2639
46. Porciatti V (2007) The mouse pattern electroretinogram. Doc Ophthalmol 115(3):145-153. doi: 10.1007/s10633-007-9059-8
47. Miura G, Wang MH, Ivers KM, Frishman LJ (2009) Retinal pathway origins of the pattern ERG of the mouse. Exp Eye Res 89(1):49-62. doi: 10.1016/j.exer.2009.02.009
48. Nagaraju M, Saleh M, Porciatti V (2007) IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci 48(10):4573-4579
49. Danias J, Lee KC, Zamora MF, Chen B, Shen F, Filippopoulos T, Su Y, Goldblum D, Podos SM, Mittag T (2003) Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57BL/6 mice. Invest Ophthalmol Vis Sci 44:5151-5162
50. Jakobs TC, Libby RT, Ben Y, John SWM, Masland RH (2005) Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171(2):313
51. Howell GR, Libby RT, Jakobs TC, Smith RS, Phalam FC, Barter JW, Barbay JM, Marchant JK, Nagaraju M, Porciatti V, Whitmore AV, Masland RH, John SWM (2007) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 179(7):1523-1537
52. Schuettauf F, Rejdak R, Walski M, Frontczak-Baniewicz M, Voelker M, Blatsios G, Shinoda K, Zagorski Z, Zrenner E, Grieb P (2004) Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol 107(4):352-358. doi: 10.1007/s00401-003-0816-9